Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO 140 SC in HIV-1 Infection
NCT00642707Phase 2Completed
- Sponsor
- CytoDyn Inc.
- Start
- Mar 2008
- Primary completion
- Nov 2008
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of leronlimab in human immunodeficiency virus type 1 infection (HIV-1), sponsored by CytoDyn Inc.. Started Mar 2008; status: completed.
02
Drugs
leronlimab
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00642707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642707.